Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

被引:48
作者
Lv, Meng [1 ]
Huang, Xiao-Jun [1 ]
机构
[1] Peking Univ, Inst Hematol, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100044, Peoples R China
基金
中国国家自然科学基金;
关键词
China; Allo-HSCT; Haploidentical; Relapse; GVHD; Elderly patients; ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSION; RISK ACUTE-LEUKEMIA; ACUTE GVHD; ANTITHYMOCYTE GLOBULIN; MYCOPHENOLATE-MOFETIL; CLINICAL-OUTCOMES; T-CELLS; BLOOD;
D O I
10.1186/1756-8722-5-10
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and sometimes the only curative therapy for patients with certain hematological diseases. Allo-HSCT has been practiced in China for approximately 30 years, and great improvements have been made within the past decade, particularly in fields such as the haploidentical HSCT system, strategies to overcome relapse and GVHD, and modified HSCT for elderly patients. This review will describe the current situation and provide a prospective of these unique aspects of Allo-HSCT in China.
引用
收藏
页数:8
相关论文
共 62 条
[1]   Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse [J].
Aversa, F ;
Terenzi, A ;
Tabilio, A ;
Falzetti, F ;
Carotti, A ;
Ballanti, S ;
Felicini, R ;
Falcinelli, F ;
Velardi, A ;
Ruggeri, L ;
Aloisi, T ;
Saab, JP ;
Santucci, A ;
Perruccio, K ;
Martelli, MP ;
Mecucci, C ;
Reisner, Y ;
Martelli, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3447-3454
[2]   Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts [J].
Brunstein, Claudio G. ;
Fuchs, Ephraim J. ;
Carter, Shelly L. ;
Karanes, Chatchada ;
Costa, Luciano J. ;
Wu, Juan ;
Devine, Steven M. ;
Wingard, John R. ;
Aljitawi, Omar S. ;
Cutler, Corey S. ;
Jagasia, Madan H. ;
Ballen, Karen K. ;
Eapen, Mary ;
O'Donnell, Paul V. .
BLOOD, 2011, 118 (02) :282-288
[3]   HLA DNA Sequence Variation among Human Populations: Molecular Signatures of Demographic and Selective Events [J].
Buhler, Stephane ;
Sanchez-Mazas, Alicia .
PLOS ONE, 2011, 6 (02)
[4]   Genetic Variations in the Mycophenolate Mofetil Target Enzyme Are Associated with Acute GVHD Risk after Related and Unrelated Hematopoietic Cell Transplantation [J].
Cao, Weijie ;
Xiao, Haowen ;
Lai, Xiaoyu ;
Luo, Yi ;
Shi, Jimin ;
Tan, Yamin ;
Zheng, Weiyan ;
He, Jingsong ;
Xie, Wanzhuo ;
Li, Li ;
Ye, Xiujin ;
Yu, Xiaohong ;
Lin, Maofang ;
Cai, Zhen ;
Huang, He .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) :273-279
[5]   Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies [J].
Chang, Ying-Jun ;
Zhao, Xiang-Yu ;
Huang, Xiao-Jun .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (03) :323-334
[6]   CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease [J].
Chen, Wei ;
Li, Miao ;
Li, Zhenyu ;
Yan, Zhiling ;
Cheng, Hai ;
Pan, Bin ;
Cao, Jiang ;
Chen, Chong ;
Zeng, Lingyu ;
Xu, Kailin .
IMMUNOLOGY LETTERS, 2012, 143 (02) :161-169
[7]   Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies [J].
Davies, Jeff K. ;
Gribben, John G. ;
Brennan, Lisa L. ;
Yuk, Dongin ;
Nadler, Lee M. ;
Guinan, Eva C. .
BLOOD, 2008, 112 (06) :2232-2241
[8]   Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms [J].
Diamond, Hilda Rachel ;
Ornellas, Maria Helena ;
Orfao, Alberto ;
Gomes, Bernadete E. ;
Campos, Mercia M. ;
Fernandez, Teresa S. ;
da Silva, Roberto I. ;
Alves, Gilda ;
Lage, Claudia ;
da Silva, Dayse A. ;
Moellmann-Coelho, Arthur ;
da Cruz, Geydson S. ;
Bouzas, Luis Fernando ;
Abdelhay, Eliana .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
[9]   Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) [J].
Estey, Elihu ;
de Lima, Marcos ;
Tibes, Raoul ;
Pierce, Sherry ;
Kantarjian, Hagop ;
Champlin, Richard ;
Giralt, Sergio .
BLOOD, 2007, 109 (04) :1395-1400
[10]   Prophylactic Effects of Interleukin-2 Receptor Antagonists against Graft-versus-Host Disease Following Unrelated Donor Peripheral Blood Stem Cell Transplantation [J].
Fang, Jun ;
Hu, Chenghao ;
Hong, Mei ;
Wu, Qiuling ;
You, Yong ;
Zhong, Zhaodong ;
Li, Weiming ;
Zou, Ping ;
Hu, Yu ;
Xia, Linghui .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (05) :754-762